Literature DB >> 26707412

Micronization, characterization and in-vitro dissolution of shellac from PGSS supercritical CO2 technique.

Philip W Labuschagne1, Brendon Naicker2, Lonji Kalombo2.   

Abstract

The purpose of this investigation was to determine whether shellac, a naturally occurring material with enteric properties, could be processed in supercritical CO2 (sc-CO2) using the particles from gas saturated solution (PGSS) process and how process parameters affect the physico-chemical properties of shellac. In-situ attenuated total reflection fourier transform infra-red (ATR-FTIR) spectroscopy showed that CO2 dissolves in shellac with solubility reaching a maximum of 13% (w/w) at 300 bar pressure and 40 °C and maximum swelling of 28%. The solubility of sc-CO2 in shellac allowed for the formation of porous shellac structures of which the average pore diameter and pore density could be controlled by adjustment of operating pressure and temperature. In addition, it was possible to produce shellac microparticles ranging in average diameter from 180 to 300 μm. It was also shown that processing shellac in sc-CO2 resulted in accelerated esterification reactions, potentially limiting the extent of post-processing "ageing" and thus greater stability. Due to additional hydrolysis reactions enhanced by the presence of sc-CO2, the solubility of shellac at pH 7.5 was increased by between 4 and 7 times, while dissolution rates were also increased. It was also shown that the in-vitro dissolution profiles of shellac could be modified by slight adjustment in operating temperatures.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dissolution; In-situ foaming; Micronization; Processing; Shellac; Supercritical carbon dioxide

Mesh:

Substances:

Year:  2015        PMID: 26707412     DOI: 10.1016/j.ijpharm.2015.12.021

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

1.  Microencapsulation of eucalyptol in polyethylene glycol and polycaprolactone using particles from gas-saturated solutions.

Authors:  Jubril Olayinka Akolade; Mohammed Balogun; Andri Swanepoel; Rasheed Bolaji Ibrahim; Abdullahi Ahmed Yusuf; Philip Labuschagne
Journal:  RSC Adv       Date:  2019-10-23       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.